health π¬ Donor Transplants Give Hope for Rare Blood Cancer
Stem cell transplantation using donor cells offers meaningful long-term survival for patients with aggressive Hepatosplenic T-cell lymphoma. Researchers analyzed outcomes from 121 adult patients across 64 centers in Europe and Asia. After three years, 55% of patients who had an allogeneic transplant were still alive, and 50.5% had not relapsed. This suggests a genuine chance of cure driven by the graft-versus-lymphoma effect. The study recommends aggressive initial chemotherapy followed by rapid allogeneic transplantation where possible. π§¬